Simultaneous analysis of gamma-hydroxybutyric acid and its precursors in urine using liquid chromatography-tandem mass spectrometry.
We have developed a rapid method that enables the simultaneous analysis of gamma-hydroxybutyrate (GHB) and its precursors, i.e. gamma-butyrolactone (GBL) and 1,4-butanediol (1,4-BD) in urine. The method comprised a simple dilution of the urine sample, followed by liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis. Chromatographic separation was achieved using an Atlantis dC18 column, eluted with a mixture of formic acid and methanol. The method was linear from 1-80 mg/L for GHB and 1,4-BD and from 1-50 mg/L for GBL. The limit of quantification was 1 mg/L for all analytes. The procedure, which has a total analysis time (including sample preparation) of less than 12 min, was fully validated and applied to the analysis of 182 authentic urine samples; the results were correlated with a previously published GC-MS procedure and revealed a low prevalence of GHB-positive samples. Since no commercial immunoassay is available for the routine screening of GHB, this simple and rapid method should prove useful to meet the current increased demand for the measurement of GHB and its precursors.
Wood
Michelle
M
Waters Corporation, MS Technologies Centre, Micromass UK Ltd., Atlas Park, Simonsway, Wythenshawe, Manchester M22 5PP, UK. michelle_wood@waters.com
Laloup
Marleen
M
Samyn
Nele
N
Morris
Michael R
MR
de Bruijn
Ernst A
EA
Maes
Robert A
RA
Young
Michael S
MS
Maes
Viviane
V
De Boeck
Gert
G
D002851:Chromatography, High Pressure Liquid / Q000379:methods*; D006801:Humans; D006885:Hydroxybutyrates / Q000652:urine*; D013058:Mass Spectrometry / Q000379:methods*; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity
D006885:Hydroxybutyrates; C111420:4-hydroxybutyric acid